BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 912211)

  • 1. Inhibition by a stable analogue of adenosine triphosphate of platelet aggregation by adenosine diphosphate.
    Born GV; Foulks JG
    Br J Pharmacol; 1977 Sep; 61(1):87-9. PubMed ID: 912211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
    Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
    Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ADP-induced aggregation of human platelets by beta, gamma-methylene-ATP.
    Evans PM
    Cytobios; 1978; 23(90):101-8. PubMed ID: 158489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5'-monophosphate and adenosine 5'-triphosphate of human platelet aggregation induced by adenosine 5'-diphosphate.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1982 Feb; 75(2):397-400. PubMed ID: 7186826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of human blood platelets with the 2',3'-dialdehyde and 2',3'-dialcohol derivatives of adenosine 5'-diphosphate and adenosine 5'-triphosphate.
    Pearce PH; Wright JM; Egan CM; Scrutton MC
    Eur J Biochem; 1978 Aug; 88(2):543-54. PubMed ID: 689037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms involved in adenosine triphosphate--induced platelet aggregation in whole blood.
    Stafford NP; Pink AE; White AE; Glenn JR; Heptinstall S
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1928-33. PubMed ID: 12893689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1982 Oct; 77(2):329-33. PubMed ID: 7139191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ADP-induced platelet aggregation by adenosine tetraphosphate.
    Harrison MJ; Brossmer R
    Thromb Haemost; 1976 Nov; 36(2):388-91. PubMed ID: 1036839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen.
    Ts'ao C
    Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.
    Park HS; Hourani SM
    Br J Pharmacol; 1999 Jul; 127(6):1359-66. PubMed ID: 10455285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of extracellular ATP metabolism in regulation of platelet reactivity.
    Birk AV; Broekman MJ; Gladek EM; Robertson HD; Drosopoulos JH; Marcus AJ; Szeto HH
    J Lab Clin Med; 2002 Sep; 140(3):166-75. PubMed ID: 12271274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of the morphological reaction of platelets to aggregating agents and of its reversal by aggregation inhibitors.
    Born GV; Dearnley R; Foulks JG; Sharp DE
    J Physiol; 1978 Jul; 280():193-212. PubMed ID: 99512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of MK-447 on platelet shape change, aggregation, and ATP release by collagen, ADP, and stable analogue of thromboxane A2 in rabbit platelets.
    Li BY; Zhou H; Qiao GF; Wang L; Li WH
    Zhongguo Yao Li Xue Bao; 1999 Jul; 20(7):627-30. PubMed ID: 10678127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antimycin and 2-deoxyglucose on adenine nucleotides in human platelets. Role of metabolic adenosine triphosphate in primary aggregation, secondary aggregation and shape change of platetets.
    Holmsen H; Setkowsky CA; Day HJ
    Biochem J; 1974 Nov; 144(2):385-96. PubMed ID: 4462589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of platelets in aspirin-sensitive bronchoconstriction in the guinea-pig; interactions with salicylic acid.
    Lefort J; Vargaftig BB
    Br J Pharmacol; 1978 May; 63(1):35-42. PubMed ID: 647162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of ATP on platelet aggregation: cation interaction and shape change.
    Wang TY; Hussey CV; Garancis JC
    Ann Clin Lab Sci; 1977; 7(1):88-92. PubMed ID: 836006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
    Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL
    Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial agonist behaviour of adenosine 5'-O-(2-thiodiphosphate) on human platelets.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1981 Jun; 73(2):405-8. PubMed ID: 7236992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the response of human blood platelets to analogues of ADP which may act as partial agonists at the ADP receptor.
    Egan CM; Fisher AP; Scrutton MC
    Eur J Biochem; 1979 Mar; 95(1):127-37. PubMed ID: 110586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.